New feline study – partnership between EpiPaws & the Cat Health Co

EpiPaws is funding the collection of omics data from a new cohort of 100 cats, managed together with its research partner, The Cat Health Company. This study will help refine the understanding of genes involved in feline aging.

The Cat Health Company is a Delaware C-Corporation. The startup aims to develop novel drugs against age-related diseases in felines.

EpiPaws is a diagnostics company based in Florida. EpiPaws is a production-level, revenue-generating company with assets in the omics space with multiple species, from companion pets to wild animals.